Caspase-2-Based Regulation of the Androgen Receptor and Cell Cycle in the Prostate Cancer Cell Line LNCaP
- PMID: 22207900
- PMCID: PMC3218410
- DOI: 10.1177/1947601911426007
Caspase-2-Based Regulation of the Androgen Receptor and Cell Cycle in the Prostate Cancer Cell Line LNCaP
Abstract
Caspase-2 can induce apoptosis in response to extrinsic and intrinsic signals. Unlike other caspases, this protein is not expressed solely in nonnuclear compartments; a subpopulation is constitutively localized in the nucleus. As one of the most evolutionarily conserved caspases, caspase-2 may have roles in multiple cellular processes. However, its contribution to nonapoptotic processes remains a mystery. In this study, we show that caspase-2 activity is important for proliferation by cells of the androgen-dependent prostate cancer cell line LNCaP. LNCaP cells expressing either a dominant-negative (dn) form of caspase or an siRNA against caspase-2 had lower androgen receptor (AR)-dependent proliferative responses than control cells, and application of the siRNA resulted in downregulation of the expression of both AR-dependent prostate-specific antigen (PSA) and AR-dependent reporter luciferase. Also, caspase-2 formed complexes with the cell cycle regulatory proteins cyclin D3, CDK4, and p21/Cip1, and caspase-2 regulated AR transactivation by inhibiting the repressive function of cyclin D3. Taken together, these results reveal, for the first time, that caspase-2 is involved in cell cycle promotion and AR activation. Given that prostate cancer cells depend on AR activity in order to survive, the fact that our data indicate that caspase-2 positively regulates AR activity suggests that caspase-2 has potential as a target in the treatment of prostate cancer.
Keywords: CDK4; DHT; LNCaP; apoptosis; caspase-2; cell cycle; cyclin D3; p21/Cip1; prostate cancer.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures






Similar articles
-
Effects of a novel carbocyclic analog of pyrrolo[2,3-d]pyrimidine nucleoside on pleiotropic induction of cell death in prostate cancer cells with different androgen responsiveness.Bioorg Med Chem Lett. 2016 Feb 15;26(4):1130-5. doi: 10.1016/j.bmcl.2016.01.057. Epub 2016 Jan 21. Bioorg Med Chem Lett. 2016. PMID: 26832220
-
6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.Chem Biol Interact. 2016 Dec 25;260:196-207. doi: 10.1016/j.cbi.2016.10.008. Epub 2016 Oct 5. Chem Biol Interact. 2016. PMID: 27720946
-
PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells.Int J Oncol. 2003 Nov;23(5):1461-70. Int J Oncol. 2003. PMID: 14532991
-
Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells.Phytother Res. 2012 May;26(5):669-74. doi: 10.1002/ptr.3616. Epub 2011 Oct 13. Phytother Res. 2012. PMID: 21997969
-
Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.Mol Cell Endocrinol. 2002 Nov 29;197(1-2):231-8. doi: 10.1016/s0303-7207(02)00263-0. Mol Cell Endocrinol. 2002. PMID: 12431817 Review.
Cited by
-
Novel roles of apoptotic caspases in tumor repopulation, epigenetic reprogramming, carcinogenesis, and beyond.Cancer Metastasis Rev. 2018 Sep;37(2-3):227-236. doi: 10.1007/s10555-018-9736-y. Cancer Metastasis Rev. 2018. PMID: 29858742 Free PMC article. Review.
-
Perspectives of gene combinations in phenotype presentation.World J Stem Cells. 2013 Jul 26;5(3):61-7. doi: 10.4252/wjsc.v5.i3.61. World J Stem Cells. 2013. PMID: 23951387 Free PMC article.
-
Caspase-2 deficiency promotes aberrant DNA-damage response and genetic instability.Cell Death Differ. 2012 Aug;19(8):1288-98. doi: 10.1038/cdd.2012.36. Epub 2012 Apr 13. Cell Death Differ. 2012. PMID: 22498700 Free PMC article.
-
Caspase-2: the reinvented enzyme.Oncogene. 2015 Apr 9;34(15):1877-82. doi: 10.1038/onc.2014.139. Epub 2014 Jun 2. Oncogene. 2015. PMID: 24882576 Review.
-
Caspase-2-mediated cell death is required for deleting aneuploid cells.Oncogene. 2017 May 11;36(19):2704-2714. doi: 10.1038/onc.2016.423. Epub 2016 Dec 19. Oncogene. 2017. PMID: 27991927 Free PMC article.
References
-
- Zhivotovsky B, Orrenius S. Caspase-2 function in response to DNA damage. Biochem Biophys Res Commun. 2005;331:859-67 - PubMed
-
- Tinel A, Tschopp J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science. 2004;304:843-6 - PubMed
-
- Baliga BC, Read SH, Kumar S. The biochemical mechanism of caspase-2 activation. Cell Death Differ. 2004;11:1234-41 - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous